Histamine in DAB induced hepatoma and effect of tritogualin and compound 48-80 on the incidence and development of the tumor.
D000818:Animals; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism* / Q000517:prevention & control; D003864:Depression, Chemical; D004149:Dioxoles / Q000627:therapeutic use; D006632:Histamine / Q000032:analysis / Q000378:metabolism*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006636:Histamine Release; D006639:Histidine; D007546:Isoquinolines / Q000627:therapeutic use*; D008099:Liver / Q000032:analysis / Q000378:metabolism; D008113:Liver Neoplasms; D010795:Phthalic Acids / Q000627:therapeutic use; D051381:Rats; D004124:p-Dimethylaminoazobenzene; D003189:p-Methoxy-N-methylphenethylamine / Q000627:therapeutic use*
D004149:Dioxoles; D006634:Histamine H1 Antagonists; D007546:Isoquinolines; D010795:Phthalic Acids; D003189:p-Methoxy-N-methylphenethylamine; D006639:Histidine; D006632:Histamine; D004124:p-Dimethylaminoazobenzene; D002262:Carboxy-Lyases